Increased serum CXCL1 and CXCL5 are linked to obesity, hyperglycemia, and impaired islet function

Journal of Endocrinology

Volumn 222, Issue 2, 2014, Pages 267-276

  Nunemaker, Craig S ^a   Chung, H Grace ^a,b   Verrilli, Gretchen M ^a,c   Corbin, Kathryn L ^a   Upadhye, Aditi ^a   Sharma, Poonam R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b University of Virginia   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Calcium; Cytokines; Diabetes; Insulin; Islet cells

Indexed keywords

CXCL1 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET CELL FUNCTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UPREGULATION;

CALCIUM; CYTOKINES; DIABETES; INSULIN; ISLET CELLS;

ANIMALS; BODY WEIGHT; CHEMOKINE CXCL1; CHEMOKINE CXCL5; DIABETES MELLITUS, TYPE 2; HYPERGLYCEMIA; ISLETS OF LANGERHANS; MICE; MICE, OBESE; OBESITY; UP-REGULATION;

EID: 84905715174     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-14-0126     Document Type: Article

References (39)

1. Boni-Schnetzler M, Ehses JA, Faulenbach M & Donath MY 2008 Insulitis in type 2 diabetes. Diabetes, Obesity & Metabolism 10(Suppl 4) 201-204.
2. Burke SJ, Lu D, Sparer TE, Masi T, Goff MR, Karlstad MD & Collier JJ 2014 NF-kB and STAT1 control CXCL1 and CXCL2 gene transcription American Journal of Physiology. Endocrinology and Metabolism 306 E131-E149.
3. Carter JD, Dula SB, Corbin KL, Wu R & Nunemaker CS 2009 A practical guide to rodent islet isolation and assessment. Biological Procedures Online 11 3-31.
4. Chavey C, Lazennec G, Lagarrigue S, Clape C, Iankova I, Teyssier J, Annicotte JS, Schmidt J, Mataki C, Yamamoto H et al. 2009 CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metabolism 9 339-349.
5. Chen L, Yang Z, Lu B, Li Q, Ye Z, He M, Huang Y, Wang X, Zhang Z, Wen J et al. 2011 Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes. Clinical Endocrinology 75 766-770.
6. Citro A,Cantarelli E,Maffi P,Nano R,Melzi R, Mercalli A,Dugnani E, Sordi V, Magistretti P, Daffonchio L et al. 2012CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. Journal of Clinical Investigation 122 3647-3651.
7. Corbin KL, Hall TE, Haile R & Nunemaker C.S. 2011 A novel fluorescence imaging approach for comparative measurements of pancreatic islet function in vitro. Islets 3 14-20.
8. Cowley MJ, Weinberg A, Zammit NW, Walters SN, Hawthorne WJ, Loudovaris T, Thomas H, Kay T, Gunton JE, Alexander SI et al. 2012 Human islets express a marked proinflammatory molecular signature prior to transplantation. Cell Transplantation 21 2063-2078.
9. Crim WS, Wu R, Carter JD, Cole BK, Trace AP, Mirmira RG, Kunsch C, Nadler JL & Nunemaker CS 2010 AGI-1067, a novel antioxidant and anti-inflammatory agent, enhances insulin release and protects mouse islets. Molecular and Cellular Endocrinology 323 246-255.
10. Donath MY, Ehses JA,Maedler K, Schumann DM, Ellingsgaard H, Eppler E & ReineckeM 2005 Mechanisms of b-cell death in type 2 diabetes. Diabetes 54(Suppl 2) S108-S113.
11. Dula SB, Jecmenica M, Wu R, Jahanshahi P, Verrilli GM, Carter JD, Brayman KL & Nunemaker CS 2010 Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling. Cell Calcium 48 133-142.
12. Eizirik DL, Cardozo AK & Cnop M.2008 The role for endoplasmic reticulum stress in diabetes mellitus. Endocrine Reviews 29 42-61.
13. Greenberg AS & McDaniel ML 2002 Identifying the links between obesity, insulin resistance and b-cell function: potential role of adipocytederived cytokines in the pathogenesis of type 2 diabetes. European Journal of Clinical Investigation 32(Suppl 3) 24-34.
14. Hakimizadeh E, Shamsizadeh A, Nazari M, Arababadi MK, Rezaeian M, Vazirinejad R, Jamali Z, Poor NM, Khorramdelazad H, Darakhshan S et al. 2013 Increased circulating levels of CXC chemokines is correlated with duration and complications of the disease in type-1 diabetes: a study on Iranian diabetic patients. Clinical Laboratory 59 531-537.
15. Higurashi M, Ohya Y, Joh K, Muraguchi M, Nishimura M, Terawaki H, Yagui K, Hashimoto N, Saito Y & Yamada K 2009 Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with type 2 diabetic nephropathy. Journal of Diabetes and its Complications 23 178-184.
16. Hoehn KL, Salmon AB, Hohnen-Behrens C, Turner N, Hoy AJ, Maghzal GJ, Stocker R, Van Remmen H, Kraegen EW, Cooney GJ et al. 2009 Insulin resistance is a cellular antioxidant defense mechanism. PNAS 106 17787-17792.
17. Igoillo-Esteve M,Marselli L, CunhaDA, Ladriere L, Ortis F,Grieco FA, Dotta F, Weir GC, Marchetti P, Eizirik DL et al. 2010 Palmitate induces a proinflammatory response in human pancreatic islets that mimics CCL2 expression by b cells in type 2 diabetes. Diabetologia 53 1395-1405.
18. Jahanshahi P, Wu R, Carter JD & Nunemaker CS 2009 Evidence of diminished glucose stimulation and endoplasmic reticulum function in nonoscillatory pancreatic islets. Endocrinology 150 607-615.
19. Klein D, Timoneri F, Ichii H, Ricordi C & Pastori RL 2008 CD40 activation in human pancreatic islets and ductal cells. Diabetologia 51 1853-1861.
20. Kovacikova M, Sengenes C, Kovacova Z, Siklova-Vitkova M, Klimcakova E, Polak J, Rossmeislova L, Bajzova M, Hejnova J, Hnevkovska Z et al. 2011 Dietary intervention-induced weight loss decreases macrophage content in adipose tissue of obese women. International Journal of Obesity 35 91-98.
21. Matos M, Park R, Mathis D& Benoist C 2004 Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. Diabetes 53 2310-2321.
22. Montane J, Cadavez L & Novials A 2014 Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 7 25-34.
23. Moore F, Santin I, Nogueira TC, Gurzov EN, Marselli L,Marchetti P& Eizirik DL 2012 The transcription factor C/EBP delta has anti-apoptotic and anti-inflammatory roles in pancreatic b cells. PLoS ONE 7 e31062.
24. Oliveira MC, Menezes-Garcia Z, Henriques MC, Soriani FM, Pinho V, Faria AM, Santiago AF, Cara DC, Souza DG, TeixeiraMM. et al. 2013 Acute and sustained inflammation and metabolic dysfunction induced by high refined carbohydrate-containing diet in mice. Obesity 21 E396-E406.
25. O'Neill CM, Lu C, Corbin KL, Sharma PR, Dula SB, Carter JD, Ramadan JW, Xin W, Lee JK & Nunemaker CS 2013 Circulating levels of IL-1BCIL-6 cause ER stress and dysfunction in islets from prediabetic male mice. Endocrinology 154 3077-3088.
26. Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M & D'Onofrio F 1995 Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38 1295-1299.
27. Poitout V & Robertson RP 2002 Minireview: secondary b-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology 143 339-342.
28. Ramadan JW, Steiner SR, O'Neill CM & Nunemaker CS 2011 The central role of calcium in the effects of cytokines on b-cell function: implications for type 1 and type 2 diabetes. Cell Calcium 50 481-490.
29. Robertson RP, Harmon J, Tran PO & Poitout V 2004 b-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53(Suppl 1) S119-S124.
30. Roland AV, Nunemaker CS, Keller SR & Moenter SM 2010 Prenatal androgen exposure programs metabolic dysfunction in female mice. Journal of Endocrinology 207 213-223.
31. Sajadi SM, Khoramdelazad H, Hassanshahi G, Rafatpanah H, Hosseini J, Mahmoodi M, Arababadi MK, Derakhshan R, Hasheminasabzavareh R, Hosseini-Zijoud SM et al. 2013 Plasma levels of CXCL1 (GRO-a) and CXCL10 (IP-10) are elevated in type 2 diabetic patients: evidence for the involvement of inflammation and angiogenesis/angiostasis in this disease state. Clinical Laboratory 59 133-137.
32. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H & Pfeiffer AF 2003 Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European prospective investigation into cancer and nutrition (EPIC)-potsdam study. Diabetes 52 812-817.
33. Straub SG & Sharp GW 2002 Glucose-stimulated signaling pathways in biphasic insulin secretion. Diabetes/Metabolism Research and Reviews 18 451-463.
34. Takahashi K, Ohara M, Sasai T, Homma H, Nagasawa K, Takahashi T, Yamashina M, Ishii M, Fujiwara F, Kajiwara T et al. 2011 Serum CXCL1 concentrations are elevated in type 1 diabetes mellitus, possibly reflecting activity of anti-islet autoimmune activity. Diabetes/Metabolism Research and Reviews 27 830-833.
35. Tang C, Koulajian K, Schuiki I, Zhang L, Desai T, Ivovic A, Wang P, Robson-Doucette C, Wheeler MB, Minassian B et al. 2012 Glucoseinduced b cell dysfunction in vivo in rats: link between oxidative stress and endoplasmic reticulum stress. Diabetologia 55 1366-1379.
36. Tecimer T, Dlott J, Chuntharapai A, Martin AW & Peiper SC 2000 Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells. Archives of Pathology & Laboratory Medicine 124 520-525.
37. Watt MJ, Hoy AJ, Muoio DM & Coleman RA 2012 Distinct roles of specific fatty acids in cellular processes: implications for interpreting and reporting experiments. American Journal of Physiology. Endocrinology and Metabolism 302 E1-E3.
38. Wellen KE & Hotamisligil GS 2003 Obesity-induced inflammatory changes in adipose tissue. Journal of Clinical Investigation 112 1785-1788.
39. Westwell-Roper C, Dai DL, Soukhatcheva G, Potter KJ, van Rooijen N, Ehses JA & Verchere CB 2011 IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. Journal of Immunology 187 2755-2765.